Here is a consolidated review of material insider trades reported on Tuesday that reflect transactions executed in late July and early August 2026. The disclosures cover multiple industries and include both concentrated purchases by directors and sizable sales by large shareholders and executives.
Top purchases
NextCure, Inc. - ADAR1 Capital Management, LLC, identified as a 10% owner and director, completed multiple buys on July 30 and July 31, 2026, acquiring common shares totaling $1,624,120. The investment firm purchased 329,153 shares of NextCure common stock at prices between $4.80 and $5.00 per share. After these transactions ADAR1 Capital Management, LLC indirectly holds 722,419 shares of NextCure common stock. The buying activity was disclosed as NextCure shares traded at $4.40 - a price near a one-week fall of almost 19%. InvestingPro analysis cited in the filings indicates the stock appears undervalued relative to its Fair Value estimate and that the company carries more cash than debt on its balance sheet.
Albertsons Companies, Inc. - Sharon McCollam, President and Chief Financial Officer, made a direct purchase of Albertsons Class A common stock on July 31, 2026, acquiring 9,000 shares at $11.48 per share for a total of $103,320. The transaction was reported as the stock trades close to a 52-week low of $10.86, and amid a 38% decline over the past year.
Goosehead Insurance, Inc. - Director Peter R. Lane bought 1,600 shares of the company’s Class A common stock on July 31, 2026, at $63.14 per share, representing $101,024 in consideration. Following the purchase Mr. Lane directly holds 1,600 shares. At the time of the filing Goosehead’s common stock was quoted at $65.66 and the company had a market capitalization of $2.33 billion. InvestingPro commentary attached to the disclosures described GSHD as appearing undervalued at current levels and flagged that management has been actively repurchasing shares, a context noted alongside the director’s purchase.
Rocky Brands, Inc. - Director Dwight Eric Smith added to his holdings on July 30, 2026, purchasing 500 shares of Rocky Brands common stock at $48.63 per share for a total cost of $24,315, according to a Form 4 filing. After this transaction Mr. Smith directly holds 16,346 shares. The filing noted Rocky Brands shares have risen nearly 100% over the past year and were trading at $50.78 at the time of disclosure, just below a 52-week high of $51.41. The stock has gained 75% year-to-date and was trading at a price-to-earnings ratio of roughly 13.
Top sales
Butterfly Network, Inc. - The most sizable insider disposition reported was by director Larry Robbins, who sold a total of $13,981,723 worth of Class A common stock across two transactions in late July and early August 2026. The sale prices ranged from $7.3925 to $8.1048 per share. On July 31, 2026, Mr. Robbins sold 1,720,129 shares at a weighted average price of $7.3925 per share, with execution prices in the range of $7.2282 to $7.82. Documents state these shares were transferred by Glenview Capital Master Fund, Ltd. to GCM Onshore Investors, L.P. and GCM Cayman Investors, Ltd. on July 1, 2026; the latter entities subsequently sold the shares. The filings note Butterfly Network’s stock has returned about 475% over the past year, and InvestingPro analysis suggests the shares are trading above their Fair Value estimate.
General Motors Company - Grant Michael Dixton, an Executive Vice President, sold 40,000 shares of GM common stock on August 3, 2026. The shares were sold at a weighted average price of $88.44, with individual transactions ranging from $87.31 to $90.04, yielding proceeds of approximately $3.54 million. The filings place this transaction as GM traded near a 52-week high of $91.85 after a 68% gain over the past year. The sale followed the vesting of 79,132 restricted stock units (RSUs) on July 30, 2026, which converted into an equal number of common shares. The same filings also record that on July 30, Mr. Dixton disposed of 35,056 shares at $88.4, a transaction valued at roughly $3.10 million that was described as likely to cover tax obligations arising from the RSU vesting.
Rush Enterprises, Inc. - Steven L. Keller, Chief Financial Officer and Treasurer, sold a total of 22,500 shares of Rush Enterprises Class A common stock on July 30 and July 31, 2026, for aggregate proceeds of about $1,817,054. On July 30 Mr. Keller sold 1,822 shares at a weighted average price of $81.1187, with individual trade prices between $81.00 and $81.3731. On July 31 he sold 20,678 shares at a weighted average price of $80.7262, with prices in that batch ranging from $80.50 to $80.86. At the time of reporting, Rush shares were trading at $80.96, near a 52-week high of $83.50 and reflecting a 51% year-to-date gain. The filings show these sales followed the exercise of options to acquire an equal number of shares, with the exercise price noted as $15.06 per share on both days.
Entrada Therapeutics, Inc. - Two material shareholders reduced stakes in Entrada over two days. Both 5AM Ventures V, L.P. and director Kush Parmar sold common stock representing $807,027 each. On July 30, 5AM Ventures V sold 114,756 shares at a weighted average price of $6.93 per share, with execution prices ranging from $6.75 to $6.95; an additional 1,718 shares were sold on July 31 at $6.85 per share. Kush Parmar’s filings mirror that pattern, disposing of 114,756 shares on July 30 at the $6.93 weighted average and 1,718 shares on July 31 at $6.85. The disclosures highlight that TRDA stock had moved up 24.5% over the previous week and was trading at $7.26, which places the market price above the reported sale prices.
Context and observable patterns
Across the reported filings several clear patterns are visible without inferring motives beyond the disclosures. Some purchases - notably ADAR1 Capital Management’s buy of NextCure and individual director buys at Albertsons, Goosehead and Rocky Brands - increase insider exposure to companies where the filings or attached InvestingPro commentary characterize shares as trading below Fair Value or note active share repurchase programs. Conversely, several large sales recorded in the disclosures followed corporate equity events such as RSU vesting or option exercises, which are explicitly referenced in the filings for GM and Rush Enterprises. Other large disposals involved transfers between investment vehicles prior to public sale, as noted in the Butterfly Network filing.
Where documentation supplies context, it is included in the disclosures: the vesting of RSUs, option exercises and prior transfers of shares between funds are cited as factual events associated with particular transactions. The filings provide price ranges, share counts and aggregate dollar amounts for each transaction, permitting a clear accounting of who bought or sold, when those actions occurred, and at what price points.
Takeaway for market participants
For investors tracking insider activity, the filings illustrate a mixed signal environment. Concentrated buys by owners and directors can represent a strengthening of insider exposure in companies that some analyses characterize as undervalued, while large disposals often coincide with scheduled or predictable equity events such as option exercises and RSU vestings. The raw disclosures allow market participants to see trade sizes, execution prices and timing, but they do not provide explicit, uniform motives for each transaction beyond the limited factual context included in the filings.
Monitoring these transactions may be useful to assess where insiders are increasing or decreasing direct ownership, especially when combined with valuation commentary and balance-sheet notes provided in the same disclosures.
Data note
The summary above is based on the Form 4 and related filings disclosed for trades occurring in late July and early August 2026. It includes transactions announced on Tuesday’s filing updates and relies on the exact share counts, prices, dates and dollar amounts reported in those documents.